Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fibromatosis, Gingival, 2 × Istiratumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Insulin-Like Growth Factor I, Resistance To 1 Fibromatosis, Gingival, 2 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

seribantumab 2 Gemcitabine 2 Docetaxel 2 130-nm albumin-bound paclitaxel 2 patritumab 1 enzalutamide 1 Istiratumab 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02399137 2018-09-18

CARRIE

Merrimack Pharmaceuticals

Phase 2 Completed

Gastrointestinal

Fibromatosis, Gingival, 2, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡